Press Release: Sanofi Q3: 15.7% sales growth boosted by earlier-than-anticipated vaccine sales
… chronic obstructive pulmonary disease (COPD) and an eosinophilic phenotype. Dupixent is the first biologic medicine approved in the US to treat …
… chronic obstructive pulmonary disease (COPD) and an eosinophilic phenotype. Dupixent is the first biologic medicine approved in the US to treat …
